Criticism of the CEO choice shows a real lack of respect for the team who have got us this far. Peter and his colleagues have persisted with the neuro-morphic aim and have delivered Akida through design, testing, redesign and now to manufacture and validation. In the period without a CEO Peter handled the role well.
BRN is a small, tight, collegiate ship, with a single aim. It does not need someone skilled at managing many departments and lines of product. They have chosen someone who adds the missing skill of connecting and explaining the chip to companies whose products or ideas could be massively improved by integrating Akida. He knows the zeitgeist and the people.In my view
it its a good choice, made by men of good judgement, and will bring good results.
- Forums
- ASX - By Stock
- BRN
- Ann: Appointment of Sean Hehir as CEO
Ann: Appointment of Sean Hehir as CEO, page-482
-
-
- There are more pages in this discussion • 193 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRN (ASX) to my watchlist
(20min delay)
|
|||||
Last
28.0¢ |
Change
-0.015(5.08%) |
Mkt cap ! $552.2M |
Open | High | Low | Value | Volume |
29.5¢ | 30.0¢ | 27.5¢ | $6.297M | 22.13M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
44 | 1370975 | 27.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.5¢ | 1073647 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
43 | 1320975 | 0.275 |
48 | 1391142 | 0.270 |
14 | 575137 | 0.265 |
16 | 333306 | 0.260 |
7 | 126883 | 0.255 |
Price($) | Vol. | No. |
---|---|---|
0.285 | 1073647 | 14 |
0.290 | 678311 | 14 |
0.295 | 941871 | 17 |
0.300 | 1088061 | 27 |
0.305 | 934255 | 14 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online